View More View Less
  • 1 University of Shahed Department of Microbiology, School of Medicine Tehran Iran
  • | 2 Ilam University of Medical Sciences Department of Microbiology, School of Medicine Ilam Iran
  • | 3 Tehran University of Medical Sciences Department of Microbiology, School of Medicine Tehran Iran
  • | 4 Lancaster University Mathematics and Statistics Department, Fylde College Lancaster UK
  • | 5 Ilam University of Medical Sciences School of Medicine, Department of Microbiology 69391-77143 Ilam Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

The rapid identification of relevant bacterial pathogens is of utmost importance in clinical settings. The aim of this study was to test a rapid identification technique for A. baumannii strains from Tehran Hospitals and to determine the antibiotic resistance profiles of the isolates. A hundred strains of Acinetobacter spp. grown from clinical specimens were identified as A. baumannii by conventional methods. Using PCR a blaOXA-51 -like gene was detected in all A. baumannii isolates but not in other species of acinetobacter. More than half of the isolates proved resistant to a variety of antibiotics by the disk diffusion technique. The rate of resistance to gentamicin, imipenem, ampicillin-sulbactam and amikacin was determined to be 45%, 53%, 62% and 62%, respectively. Moreover, most isolates (more than 90%) showed resistance to cephalosporins. This study shows that the demonstration of the blaOXA-51-like gene is a reliable and rapid way for the presumptive identification of A. baumannii and reveals that the rate of antibiotic resistance is high in Iranian A. baumannii isolates to a variety of antibiotics.

  • Taherikalani, M., Etemadi, G., Geliani, K. N., Fatollahzadeh, B., Soroush, S., Feizabadi, M. M.: Emergence of multi and pan-drug resistance Acinetobacter baumannii carrying bla(OXA-type)-carbapenemase genes among burn patients in Tehran, Iran. Saudi Med. J. 29 , 623–624 (2008).

    Feizabadi M. M. , 'Emergence of multi and pan-drug resistance Acinetobacter baumannii carrying bla(OXA-type)-carbapenemase genes among burn patients in Tehran ' (2008 ) 29 Iran. Saudi Med. J. : 623 -624.

    • Search Google Scholar
  • Feizabadi, M. M., Fathollahzadeh, B., Taherikalani, M. et al.: Antimicrobial susceptibility patterns and distribution of bla(OXA) genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Japan J. Infect. Dis. 61 , 274–278 (2008).

    Taherikalani M. , 'Antimicrobial susceptibility patterns and distribution of bla(OXA) genes among Acinetobacter spp. isolated from patients at Tehran hospitals ' (2008 ) 61 Japan J. Infect. Dis. : 274 -278.

    • Search Google Scholar
  • Taherikalani, M., Fatolahzadeh, B., Emaneini, M., Soroush, S., Feizabadi, M. M.: Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran Hospitals. New Microbiol. 32 , 265–271 (2009).

    Feizabadi M. M. , 'Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran Hospitals ' (2009 ) 32 New Microbiol : 265 -271.

    • Search Google Scholar
  • Bou, G., Cervero, G., Dominguez, M. A., Quereda, C., Martinez-Beltran, J.: Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J. Clin. Microbiol. 38 , 3299–3305 (2000).

    Martinez-Beltran J. , 'Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases ' (2000 ) 38 J. Clin. Microbiol. : 3299 -3305.

    • Search Google Scholar
  • Canduela, M. J., Gallego, L., Sevillano, E., Valderrey, C., Calvo, F., Perez, J.: Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections. J. Antimicrob. Chemother. 57 , 1220–1222 (2006).

    Perez J. , 'Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections ' (2006 ) 57 J. Antimicrob. Chemother. : 1220 -1222.

    • Search Google Scholar
  • Hujer, K. M., Hujer, A. M., Hulten, E. A. et al.: Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50 , 4114–4123 (2006).

    Hulten E. A. , 'Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center ' (2006 ) 50 Antimicrob. Agents Chemother. : 4114 -4123.

    • Search Google Scholar
  • Brown, S., Young, H. K., Amyes, S. G.: Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect. 11 , 1–23 (2005).

    Amyes S. G. , 'Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina ' (2005 ) 11 Clin. Microbiol. Infect. : 1 -23.

    • Search Google Scholar
  • Heritier, C., Poirel, L., Fournier, P. E., Claverie, J. M., Raoult, D., Nordmann, P.: Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii . Antimicrob. Agents Chemother. 49 , 4174–4179 (2005).

    Nordmann P. , 'Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii ' (2005 ) 49 Antimicrob. Agents Chemother. : 4174 -4179.

    • Search Google Scholar
  • Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., Pitt, T. L.: Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44 , 2974–2976 (2006).

    Pitt T. L. , 'Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species ' (2006 ) 44 J. Clin. Microbiol. : 2974 -2976.

    • Search Google Scholar
  • Evans, B. A., Hamouda, A., Towne, r K. J., Amyes, S. G.: OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii . Clin. Microbiol. Infect. 14 , 268–275 (2008).

    Amyes S. G. , 'OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii ' (2008 ) 14 Clin. Microbiol. Infect. : 268 -275.

    • Search Google Scholar
  • Henwood, C. J., Gatward, T., Warner, M. et al.: Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J. Antimicrob. Chemother. 49 , 479–487 (2002).

    Warner M. , 'Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) ' (2002 ) 49 J. Antimicrob. Chemother. : 479 -487.

    • Search Google Scholar
  • Corbella, X., Montero, A., Pujol, M. et al.: Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii . J. Clin. Microbiol. 38 , 4086–4095 (2000).

    Pujol M. , 'Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii ' (2000 ) 38 J. Clin. Microbiol. : 4086 -4095.

    • Search Google Scholar
  • Rice, L. B.: Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria. Cleve Clin. J. Med. 74 , 12–20 (2007).

    Rice L. B. , 'Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria ' (2007 ) 74 Cleve Clin. J. Med. : 12 -20.

    • Search Google Scholar
  • Philippe, J. M.: Bouvet PADG: Taxonomy of the Genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov. Acinetobacter haemolyticus sp. nov. Acinetobacter johnsonii sp. nov. and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwofii . International J. Systemitic Bacteriol. 36 , 228–240 (1986).

    Philippe J. M. , 'Bouvet PADG: Taxonomy of the Genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov. Acinetobacter haemolyticus sp. nov. Acinetobacter johnsonii sp. nov. and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwofii ' (1986 ) 36 International J. Systemitic Bacteriol. : 228 -240.

    • Search Google Scholar
  • Mostachio, A. K., van der Heidjen, I., Rossi, F., Levin, A. S., Cost, a S. F.: Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-beta-lactamases in carbapenem-resistant Acinetobacter spp. J. Med. Microbiol. 58 , 1522–1524 (2009).

    Cost a. S. F. , 'Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-beta-lactamases in carbapenem-resistant Acinetobacter spp ' (2009 ) 58 J. Med. Microbiol. : 1522 -1524.

    • Search Google Scholar
  • Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement (M100-S15). CLSI, Wayne PA, 2006.

  • Lee, Y. T., Turton, J. F., Chen, T. L. et al.: First identification of blaOXA-51 -like in non-baumannii Acinetobacter spp. J. Chemother. 21 , 514–520 (2009).

    Chen T. L. , 'First identification of blaOXA-51-like in non-baumannii Acinetobacter spp ' (2009 ) 21 J. Chemother. : 514 -520.

    • Search Google Scholar
  • Jeong, S. H., Bae, I. K., Park, K. O. et al.: Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J. Microbiol. 44 , 423–431 (2006).

    Park K. O. , 'Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea ' (2006 ) 44 J. Microbiol. : 423 -431.

    • Search Google Scholar
  • Kwon, N. Y., Kim, J. D., Pai, H. J.: The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii . Korean J. Intern. Med. 17 , 94–99 (2002).

    Pai H. J. , 'The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii ' (2002 ) 17 Korean J. Intern. Med. : 94 -99.

    • Search Google Scholar
  • Pournaras, S., Markogiannakis, A., Ikonomidis, A. et al.: Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. J. Antimicrob. Chemother. 57 , 557–561 (2006).

    Ikonomidis A. , 'Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit ' (2006 ) 57 J. Antimicrob. Chemother. : 557 -561.

    • Search Google Scholar
  • Sinha, M., Srinivasa, H.: Mechanisms of resistance to carbapenems in meropenem-resistant Acinetobacter isolates from clinical samples. Indian J. Med. Microbiol. 25 , 121–125 (2007).

    Srinivasa H. , 'Mechanisms of resistance to carbapenems in meropenem-resistant Acinetobacter isolates from clinical samples ' (2007 ) 25 Indian J. Med. Microbiol. : 121 -125.

    • Search Google Scholar
  • Turton, J. F., Ward, M. E., Woodford, N. et al.: The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii . FEMS Microbiol. Lett. 258 , 72–77 (2006).

    Woodford N. , 'The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii ' (2006 ) 258 FEMS Microbiol. Lett. : 72 -77.

    • Search Google Scholar
  • Hu, W. S., Yao, S. M., Fung, C. P., Hsieh, Y. P., Liu, C. P., Lin, J. F.: An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii . Antimicrob. Agents Chemother. 51 , 3844–3852 (2007).

    Lin J. F. , 'An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii ' (2007 ) 51 Antimicrob. Agents Chemother. : 3844 -3852.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 3 0 0
Mar 2021 9 0 0
Apr 2021 3 0 0
May 2021 11 0 0
Jun 2021 2 0 0
Jul 2021 15 0 0
Aug 2021 0 0 0